111 related articles for article (PubMed ID: 10367809)
1. Cost-effectiveness of interferon treatment for hepatitis C.
Henley E
JAMA; 1999 Jun; 281(22):2083; author reply 2084. PubMed ID: 10367809
[No Abstract] [Full Text] [Related]
2. Cost-effectiveness of interferon treatment for hepatitis C.
van Leeuwen DJ
JAMA; 1999 Jun; 281(22):2083-4. PubMed ID: 10367810
[No Abstract] [Full Text] [Related]
3. [Economic evaluation of combined therapy in chronic hepatitis C].
Casado MA; Buti M; Fosbrook L; Esteban R
Gastroenterol Hepatol; 2000 Feb; 23 Suppl 1():57-62. PubMed ID: 11968346
[No Abstract] [Full Text] [Related]
4. [Cost-effectiveness of antiviral therapy for chronic hepatitis C patients in prevention of hepatocellular cancer ].
Yoshida H; Tateishi R; Omata M
Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):511-4. PubMed ID: 15359852
[No Abstract] [Full Text] [Related]
5. Cost-effectiveness of treatment for chronic hepatitis C.
Koff RS
J Hepatol; 1999; 31 Suppl 1():255-8. PubMed ID: 10622598
[TBL] [Abstract][Full Text] [Related]
6. Cost effectiveness of direct-acting antiviral therapy for treatment-naive patients with chronic HCV genotype 1 infection in the veterans health administration.
Chan K; Lai MN; Groessl EJ; Hanchate AD; Wong JB; Clark JA; Asch SM; Gifford AL; Ho SB
Clin Gastroenterol Hepatol; 2013 Nov; 11(11):1503-10. PubMed ID: 23707354
[TBL] [Abstract][Full Text] [Related]
7. Doing battle with HCV.
Fimmel CJ
Am J Gastroenterol; 2000 Mar; 95(3):582-3. PubMed ID: 10710043
[No Abstract] [Full Text] [Related]
8. Q & A with Karen Tashima, MD new direct-acting antiviral agents offer therapeutic revolution for hepatitis C virus infection.
Korr M
R I Med J (2013); 2014 Jul; 97(7):29-30. PubMed ID: 24983018
[No Abstract] [Full Text] [Related]
9. Cost-effectiveness analysis of simeprevir in combination with peginterferon and ribavirin for treatment-naïve chronic hepatitis C genotype 1 patients in Japan.
Kuwabara H; Westerhout K; Treur M; Cerri K; Mahlich J; Yatsuhashi H
J Med Econ; 2015; 18(7):502-11. PubMed ID: 25763827
[TBL] [Abstract][Full Text] [Related]
10. Productivity improvements in hepatitis C treatment: impact on efficacy, cost, cost-effectiveness and quality of life.
Lidgren M; Hollander A; Weiland O; Jönsson B
Scand J Gastroenterol; 2007 Jul; 42(7):867-77. PubMed ID: 17558912
[TBL] [Abstract][Full Text] [Related]
11. Medical resource utilisation and healthcare costs in patients with chronic hepatitis C viral infection and thrombocytopenia.
Poordad F; Theodore D; Sullivan J; Grotzinger K
J Med Econ; 2011; 14(2):194-206. PubMed ID: 21348807
[TBL] [Abstract][Full Text] [Related]
12. Treatment of chronic hepatitis B in india: what is the cost of life?
Anand AC
Natl Med J India; 2002; 15(6):317-9. PubMed ID: 12540063
[No Abstract] [Full Text] [Related]
13. Should we await IFN-free regimens to treat HCV genotype 1 treatment-naive patients? A cost-effectiveness analysis (ANRS 95141).
Deuffic-Burban S; Schwarzinger M; Obach D; Mallet V; Pol S; Pageaux GP; Canva V; Deltenre P; Roudot-Thoraval F; Larrey D; Dhumeaux D; Mathurin P; Yazdanpanah Y
J Hepatol; 2014 Jul; 61(1):7-14. PubMed ID: 24650691
[TBL] [Abstract][Full Text] [Related]
14. Impact of completing chronic hepatitis C (CHC) treatment on post-therapy healthcare cost.
Tandon N; Balart LA; Laliberté F; Pilon D; Lefebvre P; Germain G; Prabhakar A
J Med Econ; 2014 Dec; 17(12):862-71. PubMed ID: 25215925
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of treatment for chronic hepatitis C infection.
Bernstein D
JAMA; 2003 Oct; 290(15):1993; author reply 1994. PubMed ID: 14559948
[No Abstract] [Full Text] [Related]
16. Cost-effectiveness of treatment for chronic hepatitis C infection.
Dore GJ; Thein HH
JAMA; 2003 Oct; 290(15):1993; author reply 1994. PubMed ID: 14559947
[No Abstract] [Full Text] [Related]
17. 'HepConomics': cost-effective, indeed, but how can we pay for it?
Athanasakis K; Petrakis I; Kyriopoulos J
J Viral Hepat; 2015 Aug; 22(8):682. PubMed ID: 25727161
[No Abstract] [Full Text] [Related]
18. Cost-effectiveness of telaprevir in patients with genotype 1 hepatitis C in Australia.
Warren E; Wright A; Jones B
Value Health; 2014 Dec; 17(8):792-800. PubMed ID: 25498774
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and cost-effectiveness of consensus interferon monotherapy with high-dose induction for hepatitis C patients with genotype 2.
Iwasaki Y; Tanaka H; Ikeada H; Okamoto R; Araki Y; Yabushita K; Kobashi H; Kariyama K; Kawaguchi M; Takaguchi K; Sakata T; Ando M; Sakaguchi K; Aoki N; Shiratori Y
Scand J Gastroenterol; 2011 Jan; 46(1):79-90. PubMed ID: 20822376
[TBL] [Abstract][Full Text] [Related]
20. Economics of chronic hepatitis B and hepatitis C.
Rajendra A; Wong JB
J Hepatol; 2007 Oct; 47(4):608-17. PubMed ID: 17697724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]